XCounter's share issue completed

Danderyd, 2012-11-07 16:42 CET (GLOBE NEWSWIRE) --

XCounter AB (publ):s (”XCounter” or ”Company”) share issue is completed. The share issue was made to enable the acceleration of several R&D projects to get to the market sooner with new attractive products. The share issue gives XCounter about SEK 7.8m before transaction costs. Settlement notes will be sent out tomorrow 8^th of November 2012.

The number of shares in XCounter will increase from the share issue with 457,174 shares which makes the total number of shares increase to 4,586,957 and the share capital increase from SEK 20,648,915 to SEK 22,934,785.

Subscribers for the share issue:	VisuRay PLC	300,000 shares
	Invesco	143,154 shares
	Fredrik Henckel	10,020 shares
	Konstantinos Spartiotis	4,000 shares

Financial adviser

Mangold Fondkommission is financial adviser to XCounter for this share issue.

For further information

Fredrik Henckel, CEO for XCounter AB, +46 8 622 23 17, +46 760 198 402

Jean-Philippe Flament, Chairman of the Board for XCounter AB

XCounter AB in summary

XCounter AB is a technology leader in direct conversion and photon counting digital X–ray imaging for medical, dental and industrial markets targeting to be the leading provider of high-end X-ray sensors. The Company’s share is traded at the stock exchange Nasdaq OMX First North. Mangold Fondkommission AB, telephone +46 8 503 015 50, is the Company’s Certified Adviser and Liquidity Provider. Further information about XCounter AB can be found at www.xcounter.se.

Important information

This press release is not considered to be an offer of any securities in XCounter AB, neither in US nor elsewhere, and no securities will be offered outside Sweden. This press release is not allowed to be distributed, direct or indirect, in or to US, Canada, Japan or Australia or elsewhere outside Sweden. The shares that is mentioned in this press release is not registered and will not be registered according to United States Securities Act 1933 (”Securities Act”), and is not allowed to be offered or sold in US.

XCounter's share issue completed

Attachments